Cargando…
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
High density lipoprotein (HDL) cholesterol levels and cholesterol efflux capacity (CEC) are inversely correlated with coronary artery disease (CAD) risk. Myeloperoxidase (MPO) derived oxidants and HDL proteome changes are implicated in HDL dysfunction in subjects with CAD in the United States; howev...
Autores principales: | Wang, Guisong, Mathew, Anna Vachaparampil, Yu, Haiyi, Li, Lei, He, Liyun, Gao, Wei, Liu, Xiaodan, Guo, Yanhong, Byun, Jaeman, Zhang, Jifeng, Chen, Y. Eugene, Pennathur, Subramaniam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837105/ https://www.ncbi.nlm.nih.gov/pubmed/29505607 http://dx.doi.org/10.1371/journal.pone.0193782 |
Ejemplares similares
-
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
por: Mathew, Anna V., et al.
Publicado: (2018) -
Altered HDL proteome predicts incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2021) -
Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022) -
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
por: Marsche, Gunther, et al.
Publicado: (2022) -
Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures
por: Xia, Wanying, et al.
Publicado: (2023)